InvestorsHub Logo

tradeherpete

01/24/23 6:52 PM

#399827 RE: nidan7500 #399823

They have to get rid of all the text books first. Once everything is digital, then one night you study plaques and tangles, the next morning that chapter title has been changed to;

Upstream from Plaques and Tangles...

A security clearance will be required to examine legacy theories on Alzheimer's Disease.

Steady_T

01/24/23 8:50 PM

#399836 RE: nidan7500 #399823

The FDA DOES NOT TELL companies what avenues of research to pursue. The FDA will review AB plaque trials as long as companies run them.

The NIH can fund alternative approaches to AD if it chooses to. Companies can pursue alternative approaches if they choose to.